Mirzaei SA - Search Results

1

Advances in skin gene therapy: utilizing innovative dressing scaffolds for wound healing, a comprehensive review.

Karimzadeh F, Soltani Fard E, Nadi A, Malekzadeh R, Elahian F, Mirzaei SA. Karimzadeh F, et al. Among authors: mirzaei sa. J Mater Chem B. 2024 Jun 27;12(25):6033-6062. doi: 10.1039/d4tb00966e. J Mater Chem B. 2024. PMID: 38887828 Review.

2

Human cytochrome b5 reductase: structure, function, and potential applications.

Elahian F, Sepehrizadeh Z, Moghimi B, Mirzaei SA. Elahian F, et al. Among authors: mirzaei sa. Crit Rev Biotechnol. 2014 Jun;34(2):134-43. doi: 10.3109/07388551.2012.732031. Epub 2012 Nov 1. Crit Rev Biotechnol. 2014. PMID: 23113554 Review.

3

The anticancer agent prodigiosin is not a multidrug resistance protein substrate.

Elahian F, Moghimi B, Dinmohammadi F, Ghamghami M, Hamidi M, Mirzaei SA. Elahian F, et al. Among authors: mirzaei sa. DNA Cell Biol. 2013 Mar;32(3):90-7. doi: 10.1089/dna.2012.1902. Epub 2013 Feb 1. DNA Cell Biol. 2013. PMID: 23373476 Free PMC article.

4

The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells.

Mansouri M, Mirzaei SA, Lage H, Mousavi SS, Elahian F. Mansouri M, et al. Among authors: mirzaei sa. Biochimie. 2014 Apr;99:71-6. doi: 10.1016/j.biochi.2013.11.010. Epub 2013 Nov 26. Biochimie. 2014. PMID: 24287290 Free article.

5

High-throughput bioaccumulation, biotransformation, and production of silver and selenium nanoparticles using genetically engineered Pichia pastoris.

Elahian F, Reiisi S, Shahidi A, Mirzaei SA. Elahian F, et al. Among authors: mirzaei sa. Nanomedicine. 2017 Apr;13(3):853-861. doi: 10.1016/j.nano.2016.10.009. Epub 2016 Oct 25. Nanomedicine. 2017. PMID: 27789260 Free article.

6

ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells.

Mirzaei SA, Gholamian Dehkordi N, Ghamghami M, Amiri AH, Dalir Abdolahinia E, Elahian F. Mirzaei SA, et al. Toxicol Appl Pharmacol. 2017 Dec 15;337:22-29. doi: 10.1016/j.taap.2017.10.018. Epub 2017 Oct 25. Toxicol Appl Pharmacol. 2017. PMID: 29079042 Free article.

7

Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells.

Mirzaei SA, Reiisi S, Ghiasi Tabari P, Shekari A, Aliakbari F, Azadfallah E, Elahian F. Mirzaei SA, et al. Sci Rep. 2018 Feb 22;8(1):3446. doi: 10.1038/s41598-018-21710-5. Sci Rep. 2018. PMID: 29472576 Free PMC article.

8

Unlike Butylcycloheptylprodigiosin, Isolated Undecylprodigiosin from Streptomyces parvulus Is Not a MDR1 and BCRP Substrate in Multidrug-Resistant Cancers.

Mirzaei SA, Safari Kavishahi M, Keshavarz Z, Elahian F. Mirzaei SA, et al. DNA Cell Biol. 2018 Jun;37(6):535-542. doi: 10.1089/dna.2018.4161. Epub 2018 Apr 19. DNA Cell Biol. 2018. PMID: 29672160

9

Intelligent TAT-coupled anti-HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma.

Gholamian Dehkordi N, Elahian F, Khosravian P, Mirzaei SA. Gholamian Dehkordi N, et al. Among authors: mirzaei sa. J Cell Physiol. 2019 Nov;234(11):20769-20778. doi: 10.1002/jcp.28683. Epub 2019 Apr 18. J Cell Physiol. 2019. PMID: 31001890

10

Inflammatory pathway interactions and cancer multidrug resistance regulation.

Mirzaei SA, Dinmohammadi F, Alizadeh A, Elahian F. Mirzaei SA, et al. Life Sci. 2019 Oct 15;235:116825. doi: 10.1016/j.lfs.2019.116825. Epub 2019 Sep 5. Life Sci. 2019. PMID: 31494169 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters